Metabolic syndrome (MS) (1), first coined by Haller and Hanefeld (2), is characterized as a cluster of five underlying cardiometabolic risk factors including dyslipidemia, abnormal glucose and insulin regulation, abdominal obesity and hypertension. The gene discussed is INS; the disease is metabolic syndrome.